Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neuropace Inc (NQ: NPCE )

4.330 -0.070 (-1.59%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,625
Open 4.490
Bid (Size) 4.480 (2)
Ask (Size) 4.750 (3)
Prev. Close 4.400
Today's Range 4.330 - 4.570
52wk Range 1.220 - 9.540
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga

Performance

YTD
+200.69%
+200.69%
1 Month
+184.87%
+184.87%
3 Month
+85.04%
+85.04%
6 Month
-27.59%
-27.59%
1 Year
-42.34%
-42.34%

More News

Read More
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
NeuroPace: Q2 Earnings Insights
Via Benzinga
Earnings Scheduled For August 11, 2022
Via Benzinga
Expert Ratings For NeuroPace
Via Benzinga
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
From NeuroPace, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference
From NeuroPace, Inc.
Via Globe NewsWire
NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway
From NeuroPace, Inc.
Via Business Wire
$10 Million Bet On Canoo? Check Out These 3 Stocks Under $3 Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update
From NeuroPace, Inc.
Via Globe NewsWire
NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference
From NeuroPace, Inc.
Via Globe NewsWire
NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022
From NeuroPace, Inc.
Via Globe NewsWire
NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized Epilepsy (IGE)
From NeuroPace, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
NeuroPace's Return On Capital Employed Insights
Via Benzinga
89 Biggest Movers From Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
5 Analysts Have This to Say About NeuroPace
Via Benzinga
Recap: NeuroPace Q1 Earnings
Via Benzinga
NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in Adolescents
From NeuroPace, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.